Loading stock data…
$35.12-0.02 (-0.06%)
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States.
Sanara MedTech Inc. in the Healthcare sector is trading at $35.11 with a market capitalization of $322M. Wall Street consensus targets $35.00 (3 analysts), implying a -0.3% move over the next 12 months. The stock is currently near its 52-week high of $35.34, remaining 40.8% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $28.14M↑ | $27.80M↑ | $27.55M↑ | $26.33M↑ | $25.80M |
| Gross Profit | $26.16M↑ | $25.87M↑ | $25.67M↑ | $24.46M↑ | $23.87M |
| Operating Income | $1.78M↓ | $2.65M↓ | $2.89M↓ | $2.94M↑ | $2.49M |
| Net Income | -$452,864↓ | $458,957↑ | -$1.61M↑ | -$30.41M↓ | -$2.01M |
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolys...